CA2361678A1 - Methode de modulation de la biosynthese de metabolite dans des cellules recombinees - Google Patents

Methode de modulation de la biosynthese de metabolite dans des cellules recombinees Download PDF

Info

Publication number
CA2361678A1
CA2361678A1 CA002361678A CA2361678A CA2361678A1 CA 2361678 A1 CA2361678 A1 CA 2361678A1 CA 002361678 A CA002361678 A CA 002361678A CA 2361678 A CA2361678 A CA 2361678A CA 2361678 A1 CA2361678 A1 CA 2361678A1
Authority
CA
Canada
Prior art keywords
plant
cell
expression
transcription factor
metabolite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002361678A
Other languages
English (en)
Inventor
Johan Memelink
Cornelia Theodora Elisabeth Van Der Fits
Franciscus Leonardus Hendrikus Menke
Jan Willem Kijne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Leiden
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2361678A1 publication Critical patent/CA2361678A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

L'invention concerne une méthode permettant de moduler dans une cellule l'expression d'au moins un gène intervenant dans la biosynthèse d'un métabolite ou d'un précurseur de ce dernier. Cette méthode consiste à insérer dans une cellule une séquence de nucléotides codant pour un facteur de transcription qui comprend un domaine de liaison d'ADN AP2, et/ou en modifiant l'expression d'une séquence de nucléotides codant pour un tel facteur de transcription déjà présent dans la cellule. Ladite méthode prouve son utilité dans l'amélioration de la biosynthèse de métabolites secondaires chez les plantes, tels que les alcaloïdes, dont les alcaloïdes indoliques de terpène. Cette invention concerne également une méthode permettant d'améliorer la tolérance au stress chez les plantes à l'aide de tels facteurs de transcription.
CA002361678A 1999-02-05 2000-02-07 Methode de modulation de la biosynthese de metabolite dans des cellules recombinees Abandoned CA2361678A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA199900158 1999-02-05
DKPA199900158 1999-02-05
US11938899P 1999-02-10 1999-02-10
US60/119,388 1999-02-10
PCT/NL2000/000075 WO2000046383A2 (fr) 1999-02-05 2000-02-07 Methode de modulation de la biosynthese de metabolite dans des cellules recombinees

Publications (1)

Publication Number Publication Date
CA2361678A1 true CA2361678A1 (fr) 2000-08-10

Family

ID=26063424

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002361678A Abandoned CA2361678A1 (fr) 1999-02-05 2000-02-07 Methode de modulation de la biosynthese de metabolite dans des cellules recombinees

Country Status (6)

Country Link
EP (1) EP1157119A1 (fr)
JP (1) JP2002535993A (fr)
AU (1) AU779162B2 (fr)
CA (1) CA2361678A1 (fr)
NZ (1) NZ513356A (fr)
WO (1) WO2000046383A2 (fr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888558B2 (en) 1999-11-17 2011-02-15 Mendel Biotechnology, Inc. Conferring biotic and abiotic stress tolerance in plants
US8030546B2 (en) 1998-09-22 2011-10-04 Mendel Biotechnology, Inc. Biotic and abiotic stress tolerance in plants
US7663025B2 (en) 1999-03-23 2010-02-16 Mendel Biotechnology, Inc. Plant Transcriptional Regulators
US7858848B2 (en) 1999-11-17 2010-12-28 Mendel Biotechnology Inc. Transcription factors for increasing yield
US8912394B2 (en) 2001-04-18 2014-12-16 Mendel Biotechnology Inc. Transcriptional regulation of plant disease tolerance
US6835540B2 (en) * 2001-03-16 2004-12-28 Mendel Biotechnology, Inc. Biosynthetic pathway transcription factors
WO2000070059A2 (fr) * 1999-05-14 2000-11-23 Pioneer Hi-Bred International, Inc. Genes de transduction de signaux et leurs methodes d'utilisation
WO2002015675A1 (fr) * 2000-08-22 2002-02-28 Mendel Biotechnology, Inc. Genes servant a modifier des caracteristiques de plantes iv
EP1379668B1 (fr) 2001-04-18 2009-08-19 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Utilisation de genes codant pour des pompes membranaires de transport afin de stimuler la production de metabolites secondaires dans des cellules biologiques
EP1293572A1 (fr) * 2001-09-17 2003-03-19 Syngenta Participations AG Méthode de modification de la biosynthèse de métabolites secondaires chez les cellules vegetales
US7176027B2 (en) 2001-12-20 2007-02-13 Pioneer Hi-Bred International, Inc. Genes and regulatory DNA sequences associated with stress-related gene expression in plants and methods of using the same
WO2003059928A1 (fr) * 2002-01-15 2003-07-24 Avestha Gengraine Technologies Pvt. Ltd. Polynucleotide codant un facteur de transcription a domaine ap-2
CA2811272C (fr) 2003-04-08 2016-12-20 Progenics Pharmaceuticals, Inc. Formulations pharmaceutiques contenant de la methylnaltrexone
AU2005325801A1 (en) 2005-01-31 2006-08-03 Ablynx N.V. Method for generating variable domain sequences of heavy chain antibodies
WO2006115575A1 (fr) 2005-04-20 2006-11-02 Ceres Inc. Regions regulatoires de papaveraceae
US8188223B2 (en) 2005-05-18 2012-05-29 Ablynx N.V. Serum albumin binding proteins
ES2694247T3 (es) 2005-05-20 2018-12-19 Ablynx N.V. NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
EP2102244A2 (fr) 2006-12-19 2009-09-23 Ablynx N.V. Séquences d'acides aminés dirigées contre une métalloprotéinase de la famille adam et polypeptides les comprenant à des fins de traitement de maladies et troubles liés à adam
CA2673331A1 (fr) 2006-12-19 2008-06-26 Ablynx N.V. Sequences d'acides amines dirigees contre les gpcr et polypeptides les contenant pour le traitement de maladies et de troubles lies au gpcr
JP2010522756A (ja) 2007-03-29 2010-07-08 プロジェニックス ファーマシューティカルズ，インコーポレーテッド 結晶形およびその使用
EP2650311A3 (fr) 2007-11-27 2014-06-04 Ablynx N.V. Séquences d'acides aminés dirigées contre des cytokines hétérodimériques et/ou leurs récepteurs et polypeptides les comprenant
AU2008349873B2 (en) 2008-02-06 2014-02-13 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone
GB2470328A (en) 2008-03-05 2010-11-17 Ablynx Nv Novel antigen binding dimer complexes, methods of making and uses thereof
JP2011516520A (ja) 2008-04-07 2011-05-26 アブリンクス エン．ヴェー． Ｎｏｔｃｈ経路に指向性を有するアミノ酸配列及びその使用
WO2009127691A1 (fr) 2008-04-17 2009-10-22 Ablynx N.V. Peptides capables de se lier à des protéines sériques et composés, constructions et polypeptides les comprenant
UY31875A (es) * 2008-06-06 2010-01-29 Grasslanz Technology Ltd Novedosos genes involucrados en la biosíntesis
US10005830B2 (en) 2009-03-05 2018-06-26 Ablynx N.V. Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
NZ595461A (en) 2009-04-10 2013-01-25 Ablynx Nv Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
PT2438087T (pt) 2009-06-05 2017-08-04 Ablynx Nv Construções de nanobody trivalentes de vírus sincicial respiratório humano (hrsv) para a prevenção e/ou tratamento de infeções do trato respiratório
WO2011040978A2 (fr) 2009-10-02 2011-04-07 Ludwig Institute For Cancer Research Ltd. Epitopes de ny-eso-1 immunodominants restreints par dr52b du cmh, monomères et multimères du cmh de classe ii et leur utilisation
WO2011064382A1 (fr) 2009-11-30 2011-06-03 Ablynx N.V. Séquences d'acides aminés améliorées dirigées contre le virus syncytial respiratoire humain (hrsv) et polypeptides comprenant celles-ci pour la prévention et/ou le traitement d'infections du tractus respiratoire
EP2531523A1 (fr) 2010-02-05 2012-12-12 Ablynx N.V. Peptides capables de se lier à la sérumalbumine, et composés, constructions, et polypeptides comprenant de tels peptides
AU2011328246B2 (en) 2010-11-08 2016-06-30 Ablynx N.V. CXCR2 binding polypeptides
JP6164657B2 (ja) * 2011-06-10 2017-07-19 シュティッヒティング・テクノロジッシュ・トップインスティテュート・グレーネ・ジェネティカ・（ファウンデーション・テクノロジカル・トップ・インスティテュート・グリーン・ジェネティクス） テルペン生合成を調節する転写因子
EP2723772A1 (fr) 2011-06-23 2014-04-30 Ablynx N.V. Domaines variables uniques d'immunoglobuline dirigés contre ige
US9328174B2 (en) 2012-05-09 2016-05-03 Novartis Ag Chemokine receptor binding polypeptides
WO2014087010A1 (fr) 2012-12-07 2014-06-12 Ablynx N.V. Polypeptides améliorés dirigés contre ige
NL1040254C2 (en) 2013-05-17 2014-11-24 Ablynx Nv Stable formulations of immunoglobulin single variable domains and uses thereof.
NL2013007B1 (en) 2014-06-16 2016-07-05 Ablynx Nv Methods of treating TTP with immunoglobulin single variable domains and uses thereof.
NL2013661B1 (en) 2014-10-21 2016-10-05 Ablynx Nv KV1.3 Binding immunoglobulins.
US10501541B2 (en) 2015-01-27 2019-12-10 Lava Therapeutics B.V. Single domain antibodies targeting CD1d
KR20180080337A (ko) 2015-11-27 2018-07-11 아블린쓰 엔.브이. Ｃｄ40ｌ을 억제하는 폴리펩티드
US11098113B2 (en) 2016-09-15 2021-08-24 Vib Vzw Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
BR112019010061A2 (pt) 2016-11-16 2019-08-13 Ablynx Nv polipeptídeos de recrutamento de células t capazes de se ligarem ao cd123 e tcr alfa/beta
NZ759601A (en) 2017-06-02 2023-06-30 Merck Patent Gmbh Aggrecan binding immunoglobulins
JP7249961B2 (ja) 2017-06-02 2023-03-31 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Ａｄａｍｔｓ５、ｍｍｐ１３およびアグリカンに結合するポリペプチド
TW202417517A (zh) 2017-06-02 2024-05-01 德商麥克專利有限公司 與ｍｍｐ１３結合之免疫球蛋白
CN118894939A (zh) 2017-06-02 2024-11-05 默克专利股份有限公司 结合adamts的免疫球蛋白
EP3749696A1 (fr) 2018-02-06 2020-12-16 Ablynx N.V. Méthodes de traitement d'un épisode initial de ttp avec des domaines variables uniques d'immunoglobuline
EP3935084B1 (fr) 2019-03-08 2024-06-12 LinXis B.V. Molécules de liaison internalisantes ciblant des récepteurs impliqués dans la prolifération cellulaire ou la différenciation cellulaire
WO2020245663A1 (fr) 2019-06-01 2020-12-10 Institut Pasteur Dosage ns1 à base de nanocorps pour le diagnostic spécifique d'une infection aiguë par le virus zika
KR20220049531A (ko) * 2019-08-05 2022-04-21 유니버시티 오브 버지니아 페이턴트 파운데이션 전사 인자 NtERF221 및 이의 사용 방법
CN110526961B (zh) * 2019-09-09 2021-02-19 四川大学 参与调控番茄甾体生物碱合成转录因子的应用
CN113265388B (zh) * 2020-02-14 2023-02-03 中国科学院分子植物科学卓越创新中心 一种产阿吗碱的烟草系统
BR112022017128A2 (pt) * 2020-03-04 2022-11-08 Pioneer Hi Bred Int Elementos reguladores cis-atuantes
CN111690661A (zh) * 2020-06-01 2020-09-22 云南省烟草农业科学研究院 一种烟草NtbHLH13基因突变体及分子鉴定方法和应用
JP2023541934A (ja) 2020-09-16 2023-10-04 リンクシス ベスローテン フェンノートシャップ 内在化結合分子
EP4019548A1 (fr) 2020-12-23 2022-06-29 Vrije Universiteit Brussel Vhh anti lag3 et leurs utilisations
CN115433733B (zh) 2021-06-04 2025-12-12 生物岛实验室 环状RNA Circ-ACE2翻译的多肽及其应用
IL311837A (en) 2021-10-20 2024-05-01 Takeda Pharmaceuticals Co Compositions targeting bcma and methods of use thereof
CA3262070A1 (fr) 2022-07-14 2025-06-13 Bio-Thera Solutions, Ltd. Anticorps anti-nectine-4 et son utilisation
US20240132624A1 (en) 2022-07-27 2024-04-25 Ablynx N.V. Polypeptides binding to a specific epitope of the neonatal fc receptor
AR131494A1 (es) 2022-12-23 2025-03-26 Ablynx Nv Vehículos de conjugación a base de proteína
TW202448926A (zh) 2023-02-17 2024-12-16 比利時商艾伯霖克斯公司 結合新生兒fc受體之多肽
EP4731770A1 (fr) 2023-06-22 2026-04-29 Ablynx NV Protéines chimériques pour moduler l'activité d'un récepteur de cytokine
WO2025008537A1 (fr) 2023-07-05 2025-01-09 Ablynx Nv Antagonistes de fcrn améliorés pour le traitement de maladies et de troubles liés à l'igg
WO2025051767A1 (fr) 2023-09-04 2025-03-13 Sanofi Polypeptides à utiliser dans le traitement de tumeurs exprimant le glypicane-3
TW202532432A (zh) 2023-09-22 2025-08-16 比利時商艾伯霖克斯公司 二及多價白蛋白結合劑
TW202543670A (zh) 2023-12-22 2025-11-16 比利時商艾伯霖克斯公司 用於核內投予之基於蛋白質的接合載劑
TW202542180A (zh) 2023-12-22 2025-11-01 比利時商艾伯霖克斯公司 用於位點特異性胺軛合的基於蛋白質的載體
WO2025207946A1 (fr) 2024-03-28 2025-10-02 Genzyme Corporation Polypeptides se liant à un épitope spécifique du récepteur 1 de la transferrine
US20260007757A1 (en) 2024-06-18 2026-01-08 Ablynx Nv Antibody-recruiting molecules
WO2026078159A1 (fr) 2024-10-10 2026-04-16 Ablynx Nv Agents d'activation de cellules immunitaires et procédés les comprenant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09224672A (ja) * 1996-02-21 1997-09-02 Mitsui Gyosai Shokubutsu Bio Kenkyusho:Kk 新規なｄｎａ結合タンパク質をコードするｄｎａ
US6846669B1 (en) * 1996-08-20 2005-01-25 The Regents Of The University Of California Methods for improving seeds
US5892009A (en) * 1996-09-04 1999-04-06 Michigan State University DNA and encoded protein which regulates cold and dehydration regulated genes
US6417428B1 (en) * 1996-09-04 2002-07-09 Michael F. Thomashow Plant having altered environmental stress tolerance
GB9801598D0 (en) * 1998-01-26 1998-03-25 Unilever Plc Methods and compositions for modulating flavonoid content
JP2000050877A (ja) * 1998-08-11 2000-02-22 Natl Inst Of Agrobiological Resources エチレン誘導性遺伝子群の発現を制御する転写因子
JP3183458B2 (ja) * 1998-08-12 2001-07-09 農林水産省国際農林水産業研究センター所長 植物の転写因子をコードする遺伝子
JP3178672B2 (ja) * 1998-10-14 2001-06-25 農林水産省国際農林水産業研究センター所長 環境ストレス耐性植物

Also Published As

Publication number Publication date
WO2000046383A8 (fr) 2001-11-01
AU2580600A (en) 2000-08-25
WO2000046383A3 (fr) 2001-09-07
NZ513356A (en) 2004-01-30
WO2000046383A2 (fr) 2000-08-10
JP2002535993A (ja) 2002-10-29
AU779162B2 (en) 2005-01-06
EP1157119A1 (fr) 2001-11-28

Similar Documents

Publication Publication Date Title
AU779162B2 (en) Method of modulating metabolite biosynthesis in recombinant cells
EP0904290B1 (fr) Acide nucleique codant le gene gai de l'arabidopsis
JP3782106B2 (ja) 開花の遺伝的制御
Gong et al. A constitutively expressed Myc-like gene involved in anthocyanin biosynthesis from Perilla frutescens: molecular characterization, heterologous expression in transgenic plants and transactivation in yeast cells
US6248937B1 (en) Transcription factor and method for regulation of seed development, quality and stress-tolerance
JPH06506584A (ja) 種子における脂質生合成の制御に関与する植物プロモーター
US5952545A (en) Nucleic acid molecules encoding cytochrome P450-type proteins involved in the brassinosteroid synthesis in plants
JP3183407B2 (ja) エチレンに対する修正された応答をもつ植物
US20030106089A1 (en) Cotton fiber transcriptional factors
US5932784A (en) Method for obtaining male-sterile plants
CN101935342B (zh) 蝴蝶兰花发育B族基因-PhAP3编码序列及其应用
AU4126999A (en) Cyclin-dependent kinase inhibitors as plant growth regulators
CA2350186A1 (fr) Promoteurs d'expression genique dans les racines de plantes
US6639130B2 (en) Plant sterol reductases and uses thereof
JP2002523052A (ja) ポリヌクレオチド配列
US7393946B1 (en) Method of modulating metabolite biosynthesis in recombinant cells
JP2002506345A (ja) 植物ｇｒａｂタンパク質
WO1997048793A9 (fr) Reductases de sterol de plantes et leurs utilisations
US5908971A (en) Crucifer ACC synthase and uses thereof
KR100455621B1 (ko) 화분 특이적 징크 핑거 전사 인자 유전자의 사용에 의한화분 임성의 저하방법
WO1997025433A1 (fr) Controle de la floraison de plantes
KR100443488B1 (ko) 에틸렌 합성을 조절하는 신규한 유전자
CA2329684C (fr) Inhibiteurs de la kinase dependant de la cycline, utilises comme regulateur de croissance des plantes
KR100455620B1 (ko) 벽판-특이적 아연 핑거 전사 인자 유전자를 이용한 화분수정률의 감소 방법
CA2380955C (fr) Plantes dont la reaction a l'ethylene est modifiee

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20120518